About this episode
Scott Wapner and the Investment Committee discuss the rally amid potential tariffs coming with the new administration. Plus, Amgen on pace for its worst day since October, 2000, it’s our Chart of the Day, the desk debates the name and the biotech sector. And late, the Investment Committee debate the latest Calls of the Day on Zoom and Delta.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Halftime Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Halftime Report
Protecting Your Portfolio Against Rising Oil Prices and Yields 9/10/26
Halftime Report
Navigating the Risk of a Market Correction: The Investment Committee Weighs in 9...
Halftime Report
Trading Ahead of the Apple iPhone Event & the CPI Report 9/8/26
Halftime Report
The Return of the "Magnificent Seven:" The Investment Committee's Strategy 9/4/2...
Halftime Report